13F HOLDINGS REPORT
Vida Ventures Advisors, LLC
Quarter ended Q1 2024 · Filed April 12, 2024 · Accession 0000950123-24-003271
Total Value
$180.0M
Positions
5
Other Managers
0
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Kyverna Therapeutics, Inc. | KYTX | 4,523,924 | $112.4M | 62.43% |
| 2 | Centessa Pharmaceuticals plc | CNTA | 3,931,818 | $44.4M | 24.68% |
| 3 | Dyne Therapeutics, Inc. | DYN | 407,499 | $11.6M | 6.43% |
| 4 | Allogene Therapeutics, Inc. | ALLO | 1,798,163 | $8.0M | 4.47% |
| 5 | Kronos Bio, Inc. | 50107A104 | 2,765,314 | $3.6M | 2.00% |